Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019425530> ?p ?o ?g. }
- W2019425530 endingPage "232" @default.
- W2019425530 startingPage "223" @default.
- W2019425530 abstract "Boron Neutron Capture Therapy (BNCT) is a bimodal cancer treatment based on the selective accumulation of 10B in tumors and concurrent irradiation with thermalized neutrons. The short-range, high-LET radiation produced by the capture of neutrons by 10B could potentially control tumor while sparing normal tissue if the boron compound targets tumor selectively within the treatment volume. In previous studies, we proposed and validated the hamster cheek pouch model of oral cancer for BNCT studies, proved that absolute and relative uptake of the clinically employed boron compound boronophenylalanine (BPA) would be potentially therapeutic in this model and provided evidence of the efficacy of in vivo BPA-mediated BNCT to control hamster oral mucosa tumors with virtually no damage to normal tissue. We herein present the biodistribution and pharmacokinetics of a lipophilic, carborane-containing tetraphenylporphyrin (CuTCPH) in the hamster oral cancer model. CuTCPH is a novel, non-toxic compound that may be advantageous in terms of selective and absolute delivery of boron to tumor tissues. For potentially effective BNCT, tumor boron concentrations from a new agent should be greater than 30 ppm and tumor/blood and tumor/normal tissue boron concentration ratios should be greater than 5/1 without causing significant toxicity. We administered CuTCPH intraperitoneally (i.p.) as a single dose of 32 microg/g body weight (b.w.) (10 microg B/g b.w.) or as four doses of 32 microg/g b.w. over 2 days. Blood (Bl) and tissues were sampled at 3, 6, 12, 24, 48, and 72 h in the single-dose protocol and at 1-4 days after the last injection in the multidose protocol. The tissues sampled were tumor (T), precancerous tissue surrounding tumor, normal pouch (N), skin, tongue, cheek and palate mucosa, liver, spleen, parotid gland and brain. The maximum mean B ratios for the single-dose protocol were T/N: 9.2/1 (12h) and T/Bl: 18.1/1 (72 h). The B value peaked to 20.7+/-18.5 ppm in tumor at 24h. The multidose protocol maximum mean ratios were T/N: 11.9/1 (3 days) and T/Bl: 235/1 (4 days). Absolute boron concentration in tumor reached a maximum value of 116 ppm and a mean value of 71.5+/-48.3 ppm at 3 days. The fact that absolute and relative B values markedly exceeded the BNCT therapeutic threshold with no apparent toxicity may confer on this compound a therapeutic advantage. CuTCPH-mediated BNCT would be potentially useful for the treatment of oral cancer in an experimental model." @default.
- W2019425530 created "2016-06-24" @default.
- W2019425530 creator A5002985695 @default.
- W2019425530 creator A5004332266 @default.
- W2019425530 creator A5012553025 @default.
- W2019425530 creator A5016342275 @default.
- W2019425530 creator A5018023477 @default.
- W2019425530 creator A5020442027 @default.
- W2019425530 creator A5025598164 @default.
- W2019425530 creator A5029787102 @default.
- W2019425530 creator A5038578738 @default.
- W2019425530 creator A5053636941 @default.
- W2019425530 creator A5082821373 @default.
- W2019425530 date "2003-03-01" @default.
- W2019425530 modified "2023-10-18" @default.
- W2019425530 title "Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch" @default.
- W2019425530 cites W1905286104 @default.
- W2019425530 cites W191454705 @default.
- W2019425530 cites W1972038810 @default.
- W2019425530 cites W1977934288 @default.
- W2019425530 cites W1988554636 @default.
- W2019425530 cites W1989119709 @default.
- W2019425530 cites W1991949008 @default.
- W2019425530 cites W1996682789 @default.
- W2019425530 cites W1996863402 @default.
- W2019425530 cites W1997217335 @default.
- W2019425530 cites W2002470157 @default.
- W2019425530 cites W2008768798 @default.
- W2019425530 cites W2009401675 @default.
- W2019425530 cites W2012200796 @default.
- W2019425530 cites W2013301660 @default.
- W2019425530 cites W2022948143 @default.
- W2019425530 cites W2032925210 @default.
- W2019425530 cites W2037317509 @default.
- W2019425530 cites W2037803591 @default.
- W2019425530 cites W2058077840 @default.
- W2019425530 cites W2066949739 @default.
- W2019425530 cites W2067043175 @default.
- W2019425530 cites W2069255784 @default.
- W2019425530 cites W2073271015 @default.
- W2019425530 cites W2077700093 @default.
- W2019425530 cites W2083379845 @default.
- W2019425530 cites W2085731391 @default.
- W2019425530 cites W2106724165 @default.
- W2019425530 cites W2124720318 @default.
- W2019425530 cites W2143210785 @default.
- W2019425530 cites W2151051629 @default.
- W2019425530 cites W2158185439 @default.
- W2019425530 cites W2163176102 @default.
- W2019425530 cites W2220362953 @default.
- W2019425530 cites W2317576691 @default.
- W2019425530 cites W2335622244 @default.
- W2019425530 cites W2468470429 @default.
- W2019425530 cites W4300703748 @default.
- W2019425530 doi "https://doi.org/10.1016/s0003-9969(02)00210-8" @default.
- W2019425530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12648560" @default.
- W2019425530 hasPublicationYear "2003" @default.
- W2019425530 type Work @default.
- W2019425530 sameAs 2019425530 @default.
- W2019425530 citedByCount "29" @default.
- W2019425530 countsByYear W20194255302012 @default.
- W2019425530 countsByYear W20194255302013 @default.
- W2019425530 countsByYear W20194255302014 @default.
- W2019425530 countsByYear W20194255302015 @default.
- W2019425530 countsByYear W20194255302016 @default.
- W2019425530 countsByYear W20194255302018 @default.
- W2019425530 crossrefType "journal-article" @default.
- W2019425530 hasAuthorship W2019425530A5002985695 @default.
- W2019425530 hasAuthorship W2019425530A5004332266 @default.
- W2019425530 hasAuthorship W2019425530A5012553025 @default.
- W2019425530 hasAuthorship W2019425530A5016342275 @default.
- W2019425530 hasAuthorship W2019425530A5018023477 @default.
- W2019425530 hasAuthorship W2019425530A5020442027 @default.
- W2019425530 hasAuthorship W2019425530A5025598164 @default.
- W2019425530 hasAuthorship W2019425530A5029787102 @default.
- W2019425530 hasAuthorship W2019425530A5038578738 @default.
- W2019425530 hasAuthorship W2019425530A5053636941 @default.
- W2019425530 hasAuthorship W2019425530A5082821373 @default.
- W2019425530 hasConcept C112705442 @default.
- W2019425530 hasConcept C121608353 @default.
- W2019425530 hasConcept C126322002 @default.
- W2019425530 hasConcept C150903083 @default.
- W2019425530 hasConcept C177322064 @default.
- W2019425530 hasConcept C178790620 @default.
- W2019425530 hasConcept C185592680 @default.
- W2019425530 hasConcept C202751555 @default.
- W2019425530 hasConcept C207001950 @default.
- W2019425530 hasConcept C2777807558 @default.
- W2019425530 hasConcept C2778575167 @default.
- W2019425530 hasConcept C2989005 @default.
- W2019425530 hasConcept C30421969 @default.
- W2019425530 hasConcept C34439696 @default.
- W2019425530 hasConcept C501308230 @default.
- W2019425530 hasConcept C502942594 @default.
- W2019425530 hasConcept C55493867 @default.
- W2019425530 hasConcept C71924100 @default.
- W2019425530 hasConcept C86803240 @default.
- W2019425530 hasConcept C98274493 @default.